FDA Panel Recommends Approval of Adjuvanted Bird Flu (H5N1) Vaccine .

An adjuvanted vaccine against the avian influenza virus (H5N1) has been recommended for approval by an FDA advisory panel, Reuters reported last week.

Another vaccine has already been licensed for H5N1, but the newer vaccine would require much less antigen to be effective because of the presence of the adjuvant. That would make it easier to produce enough doses during an epidemic, according to the report.

Source: Reuters


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.